2021-01-11,AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
2021-01-04,AlloVir to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-28,"Have Insiders Been Buying AlloVir, Inc. (NASDAQ:ALVR) Shares?"
2020-12-17,"AlloVir Announces FDA Clearance of Investigational New Drug Application for ALVR106, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T Cell Therapy Targeting Four Devastating Respiratory Viruses"
2020-12-11,Is ALVR A Good Stock To Buy Now?
2020-12-10,Company Profile for AlloVir
2020-12-07,Positive Phase 2 Proof-of-Concept Data for Viralym-M and Burden of Disease Data Presented in Oral Presentations at the 62nd American Society of Hematology Annual Meeting
2020-12-05,"Preclinical Data Demonstrate Anti-Viral Activity of AlloVirs ALVR109, an Allogeneic, Off-the-Shelf SARS-CoV-2 Specific T Cell Therapy"
2020-11-24,AlloVir to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-10,AlloVir Reports Third Quarter 2020 Financial Results
2020-11-04,AlloVir Announces Oral Data Presentations at 62nd American Society of Hematology Annual Meeting
2020-10-30,"Could The AlloVir, Inc. (NASDAQ:ALVR) Ownership Structure Tell Us Something Useful?"
2020-10-21,Data to Be Presented at IDWeek 2020 Demonstrate the Economic and Clinical Burden of Respiratory and Multi-Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
2020-09-21,AlloVir Gains 14% On FDA Trial Nod For Covid-19 Therapy
2020-09-17,AlloVir Announces the FDA Clearance of Investigational New Drug Application (IND) for ALVR109 for the Treatment of High-Risk COVID-19 Patients
2020-09-08,"AlloVir Appoints Ercem Atillasoy, M.D., as Chief Regulatory and Safety Officer"
2020-09-02,AlloVir Reports Second Quarter 2020 Financial Results
2020-08-25,AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
2020-08-03,AlloVir Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
2020-07-30,"AlloVir prices upsized IPO at $17, to be valued at over $1 billion"
2020-07-30,AlloVir Announces Pricing of Upsized Initial Public Offering
